Eastgate Biotech Corp. Stock Other OTC
Equities
ETBI
US2772531008
Pharmaceuticals
Sales 2015 | 0.13 0.18 | Sales 2016 | - | Capitalization | 9.82M 13.47M |
---|---|---|---|---|---|
Net income 2015 | -4M -5.49M | Net income 2016 | -2M -2.74M | EV / Sales 2015 | 52,069,161 x |
Net Debt 2015 | 1.35M 1.85M | Net Debt 2016 | 1.72M 2.36M | EV / Sales 2016 | - |
P/E ratio 2015 |
-0.85
x | P/E ratio 2016 |
-3.28
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Rose Perri
CEO | Chief Executive Officer | 55 | 15-01-14 |
William Abajian
PSD | President | 66 | 16-05-31 |
Ishaan Sundar
CTO | Chief Tech/Sci/R&D Officer | - | 17-04-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anna Gluskin
BRD | Director/Board Member | 68 | 12-05-21 |
Rose Perri
CEO | Chief Executive Officer | 55 | 15-01-14 |
1st Jan change | Capi. | |
---|---|---|
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |